State Ledger
Company profile

MAIA Biotechnology, Inc. CIK 1878313

Ticker
MAIA (NYSE)
Industry
Pharmaceutical Preparations
Headquarters
Chicago, IL 60606
Fiscal year end
2025 (FY)
Market Data
Close
$1.17
Change
+$0.00
Change %
0.00%
Volume
11,229

MAIA · trading date Oct 13, 2026 · previous close $1.17 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
—
Net income
-$22.40M
Total assets
$9.70M
Total liabilities
$7.33M
Stockholders' equity
$2.38M
Cash & equivalents
$0
Operating income
-$24.27M
Operating cash flow
-$18.84M
Capital expenditures
—

Fiscal year 2025, via 10-K filed 2026-03-23. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
—
Free cash flow
—
Free cash flow margin
—
Liabilities / assets
75.5%
Equity / assets
24.5%
CapEx / revenue
—
Operating cash flow / net income
0.84×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 — -$22.40M $9.70M $7.33M $2.38M
2024 $0 -$23.25M $10.16M $6.52M $3.63M
2023 $0 -$19.77M $7.57M $7.09M $477.5K
2022 $0 -$16.22M $12.02M $3.51M $8.51M
2021 — -$12.50M $11.33M $2.15M $9.18M
Company Details
SIC code
2834
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 4
2026-09-15
Financials filed via
Form 10-K
filed 2026-03-23

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Chicago, IL 60606
444 WEST LAKE STREET, SUITE 1700
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:30 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to Illinois — Public Companies